Follow The Filings

FTH Faeth Therapeutics

Faeth Therapeutics earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by FTH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All FTH insider trades
  • $2.5M bought by 3 insiders
  • $2.3M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Brian C Stephenson CFO
    Buy
    $326K 13,634 shares at $23.92 +41% to stake
    Traded Jun 29–Jul 1 Filed Jul 1
    ↗
  2. Brian C Stephenson CFO
    Buy
    $401K 15,641 shares at $25.65 +90% to stake
    Traded Jun 24–26 Filed Jun 26
    ↗
  3. Anand Kiran Parikh CEO
    Buy
    $55K 2,806 shares at $19.76 +0.4% to stake
    Traded Jun 22 Filed Jun 24
    ↗
  4. Brian C Stephenson CFO
    Buy
    $406K 17,413 shares at $23.31 New stake
    Traded Jun 22–23 Filed Jun 24
    ↗
  5. Cambrian BioPharma Inc 10% owner
    Sale
    $501K 25,000 shares at $20.02 16% of stake
    Traded Jun 1 Filed Jun 1
    ↗
  6. Millennium Management LLC 10% owner, +3 joint filers
    Sale
    $538K 17,076 shares at $31.51 11% of stake
    Traded Apr 2–7 Filed May 15
    ↗
  7. Millennium Management LLC 10% owner, +3 joint filers
    Buy
    $141K 4,215 shares at $33.54 +3.2% to stake
    Traded Apr 2–7 Filed May 15
    ↗
  8. Millennium Management LLC 10% owner, +3 joint filers
    Buy
    $382K 12,180 shares at $31.37 +9% to stake
    Traded Mar 31–Apr 1 Filed May 15
    ↗
  9. Millennium Management LLC 10% owner, +3 joint filers
    Sale
    $77K 2,741 shares at $28.07 1.8% of stake
    Traded Mar 31–Apr 1 Filed May 15
    ↗
  10. Millennium Management LLC 10% owner, +3 joint filers
    Buy
    $818K 30,585 shares at $26.75 +27% to stake
    Traded Mar 26–30 Filed May 15
    ↗
  11. Millennium Management LLC 10% owner, +3 joint filers
    Sale
    $89K 3,250 shares at $27.50 2.2% of stake
    Traded Mar 26–30 Filed May 15
    ↗
  12. Cambrian BioPharma Inc 10% owner
    Sale
    $55K 6,612 shares at $8.25 4.1% of stake
    Traded Dec 9, 2025 Filed Dec 10, 2025
    ↗
  13. James Peyer 10% owner
    Sale
    $55K 6,612 shares at $8.25 4.1% of stake
    Traded Dec 8–9 Filed Dec 10, 2025
    ↗
  14. Cambrian BioPharma Inc 10% owner
    Sale
    $233K 21,295 shares at $10.93 12% of stake
    Traded Dec 4–5 Filed Dec 8, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 4 option exercises and 2 conversions.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 1.02,5.02,5.03,7.01,8.01,9.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K/A Filing Doc
8-K 8.01 Filing Doc
DEFA14A Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.